The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers
- 3 September 2015
- journal article
- Published by Springer Nature in Cellular Oncology
- Vol. 38 (6) , 443-451
Abstract
Connexin 43 (Cx43) is a widely expressed gap junction protein. It can also regulate various gap-junction independent processes, including cellular proliferation. The latter regulatory functions have been attributed to its carboxy-terminal domain, CT-Cx43. CT-Cx43 has been found to be expressed independent of full-length Cx43 in various cell types. Its nuclear localization has additionally raised the possibility that it may regulate the expression of particular genes, including miRNAs, known play a role in the regulation of cellular proliferation. Here, we set out to uncover the molecular mechanism(s) underlying CT-Cx43 mediated gene (de-)regulation in human breast cancer. Western blotting and quantitative real time PCR were carried to assess the expression of CT-Cx43 and miR-125b in a panel of 60 primary human breast cancer tissues and its paired normal adjacent tissues. In addition, CT-Cx43 was exogenously expressed in the breast cancer-derived cell line MCF-7 and its effect on the expression of miR-125b and its downstream target p53 were evaluated, as well as its effect on cellular proliferation and death using MTT and LDH assays, respectively. We found that CT-Cx43, but not full-length Cx43, was down-regulated in low grade human breast cancers. In addition, we found that the tumor suppressor protein p53 exhibited a decreased expression in the CT-Cx43 down-regulated samples. Interestingly, we found that miR-125b, a negative regulator of p53, exhibited an inverse expression relationship with CT-Cx43 in the breast cancer samples tested. This inverse relationship was confirmed by exogenous expression of CT-Cx43 in MCF-7 cells. In addition, we found that CT-Cx43 up-regulation and subsequent miR-125b down-regulation resulted in a decreased proliferation of MCF-7 cells. Our data suggest a mechanism by which CT-Cx43 may regulate cell proliferation. Targeting of CT-Cx43 and/or miR-125b may be instrumental for therapeutic intervention in human breast cancer.Keywords
This publication has 40 references indexed in Scilit:
- miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-α, CCNJ, and MEGF9PLOS ONE, 2013
- miR-125b regulates side population in breast cancer and confers a chemoresistant phenotypeJournal of Cellular Biochemistry, 2013
- Micro-RNAs (miRNAs): genomic organisation, biogenesis and mode of actionCell and tissue research, 2012
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast CancerPLOS ONE, 2012
- Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of TumorigenesisGenes & Cancer, 2011
- Physiological and physiopathological aspects of connexins and communicating gap junctions in spermatogenesisPhilosophical Transactions of the Royal Society B: Biological Sciences, 2010
- Connexins: a myriad of functions extending beyond assembly of gap junction channelsCell Communication and Signaling, 2009
- Downregulation of wild-type p53 protein by HER-2/neu mediated PI3K pathway activation in human breast cancer cells: its effect on cell proliferation and implication for therapyCell Research, 2004
- Gene expression alterations in connexin null mice extend beyond the gap junctionNeurochemistry International, 2004
- DNA damage activates p53 through a phosphorylation–acetylation cascadeGenes & Development, 1998